The role of estrogen, androgen and progestogen receptors in the management of carcinoma of the prostate
- PMID: 545809
The role of estrogen, androgen and progestogen receptors in the management of carcinoma of the prostate
Abstract
Identification of specific 17-beta-estradiol, 5-alpha-dihydrotestosterone and progesterone binding proteins in 10 patients with metastatic adenocarcinoma of the prostate is presented. A synthetic androgen radioligand (R1881) and a synthetic progesterone (R5020) were used. In all but 1 patient receptor protein assays were done before hormonal manipulation. Based on the preliminary findings it seems probable that prostatic carcinoma might be categorized for endocrine therapy similar to the method used for carcinoma of the breast.
Similar articles
-
Adenocarcinoma of prostate: role of 17beta-estradiol and 5alpha-dihydrotestosterone binding proteins.Urology. 1979 Jun;13(6):597-603. doi: 10.1016/0090-4295(79)90378-9. Urology. 1979. PMID: 452193
-
[Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].Sov Med. 1984;(6):32-6. Sov Med. 1984. PMID: 6205454 Russian. No abstract available.
-
[Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].Urol Nefrol (Mosk). 1984 Jul-Aug;(4):41-6. Urol Nefrol (Mosk). 1984. PMID: 6474626 Russian. No abstract available.
-
Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.Invest Urol. 1978 Nov;16(3):169-74. Invest Urol. 1978. PMID: 361632 Review. No abstract available.
-
Morphologic assay of steroid hormone receptors in human neoplasia.Pathol Annu. 1980;15(Pt 2):143-80. Pathol Annu. 1980. PMID: 6161331 Review. No abstract available.
Cited by
-
Analysis of changes in rat prostate carcinoma following hormone deprivation.Am J Pathol. 1987 Sep;128(3):566-72. Am J Pathol. 1987. PMID: 3307445 Free PMC article.